Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.

Name: Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.
Author: Dai, Xianping

Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway. — المؤلف: Dai, Xianping — Medical science monitor : international medical journal of experimental and c

المؤلف: Dai, Xianping
النشر: Medical science monitor : international medical journal of experimental and clinical research 20190201
الوصف: 8669-8677 p.
الموضوعات: Aged؛ Aged, 80 and over؛ Antineoplastic Agents؛ Apoptosis؛ Breast Neoplasms؛ Cell Line, Tumor؛ Cell Movement؛ Cell Proliferation